Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Operating Income (2016 - 2025)

Historic Operating Income for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $2.6 million.

  • Utah Medical Products' Operating Income fell 2189.65% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year decrease of 1860.62%. This contributed to the annual value of $2.8 million for FY2024, which is 1909.63% up from last year.
  • Utah Medical Products' Operating Income amounted to $2.6 million in Q3 2025, which was down 2189.65% from $3.2 million recorded in Q2 2025.
  • Utah Medical Products' 5-year Operating Income high stood at $5.1 million for Q3 2022, and its period low was $2.6 million during Q3 2025.
  • Its 5-year average for Operating Income is $4.1 million, with a median of $4.0 million in 2023.
  • As far as peak fluctuations go, Utah Medical Products' Operating Income skyrocketed by 14102.18% in 2021, and later crashed by 2570.99% in 2024.
  • Utah Medical Products' Operating Income (Quarter) stood at $5.1 million in 2021, then fell by 1.17% to $5.1 million in 2022, then fell by 22.21% to $3.9 million in 2023, then decreased by 25.71% to $2.9 million in 2024, then dropped by 10.89% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $3.2 million for Q2 2025, and $3.2 million during Q1 2025.